Research Article
You have full text access to this OnlineOpen article
Epstein-Barr virus load in the peripheral blood of patients with rheumatoid arthritis: Accurate quantification using real-time polymerase chain reaction
Article first published online: 6 MAY 2003
DOI: 10.1002/art.10933
Copyright © 2003 by the American College of Rheumatology
Additional Information
How to Cite
Balandraud, N., Meynard, J. B., Auger, I., Sovran, H., Mugnier, B., Reviron, D., Roudier, J. and Roudier, C. (2003), Epstein-Barr virus load in the peripheral blood of patients with rheumatoid arthritis: Accurate quantification using real-time polymerase chain reaction. Arthritis & Rheumatism, 48: 1223–1228. doi: 10.1002/art.10933
Publication History
- Issue published online: 6 MAY 2003
- Article first published online: 6 MAY 2003
- Manuscript Accepted: 14 JAN 2003
- Manuscript Received: 24 SEP 2002
Funded by
- INSERM
- Société Française de Rhumatologie
- Association pour la Recherche sur la Polyarthrite
- Abstract
- Article
- References
- Cited By
Cited in:
- CrossRef
This article has been cited by:
- 1, CD8+ T-Cell Deficiency, Epstein-Barr Virus Infection, Vitamin D Deficiency, and Steps to Autoimmunity: A Unifying Hypothesis, Autoimmune Diseases, 2012, 2012, 1
- 2, , , , , , , , , , , , , Clinicopathological analyses in patients with other iatrogenic immunodeficiency-associated lymphoproliferative diseases and rheumatoid arthritis, Leukemia & Lymphoma, 2012, 53, 4, 616
- 3, , , , , , , Epstein-Barr Virus as a Trigger of Autoimmune Liver Diseases, Advances in Virology, 2012, 2012, 1
- 4, , , , Epstein-Barr virus serologic abnormalities and risk of rheumatoid arthritis among women, Autoimmunity, 2012, 45, 2, 161
- 5, , , , , Genes, epigenetic regulation and environmental factors: Which is the most relevant in developing autoimmune diseases?, Autoimmunity Reviews, 2012, 11, 8, 604
- 6, , , , , Metastasin S100A4 is increased in proportion to radiographic damage in patients with RA, Rheumatology, 2012, 51, 5, 932
- 7, Autoimmune disease: A role for new anti-viral therapies?, Autoimmunity Reviews, 2011, 11, 2, 88
- 8, Autoimmune-like syndromes during TNF blockade: does infection have a role?, Nature Reviews Rheumatology, 2011, 7, 7, 429
- 9, , , , , Prospective monitoring of EpsteinâBarr virus and other herpesviruses in patients with juvenile idiopathic arthritis treated with methotrexate and tocilizumab, Modern Rheumatology, 2011,
- 10, The role of the Epstein-Barr virus in the pathogenesis of some autoimmune disorders â Similarities and differences, European Journal of Microbiology and Immunology, 2011, 1, 4, 267
- 11, , , , A Study of the Association Between Smoking and Rheumatoid Arthritis, The Journal of Smoking Cessation , 2010, 5, 1, 1
- 12
- 13, , , , Development of a quantitative assay to measure EBV viral load in patients with autoimmune type 1 diabetes and healthy subjects, Journal of Virological Methods, 2010, 164, 1-2, 111
- 14, , , , , Epstein-Barr virus in bone marrow of rheumatoid arthritis patients predicts response to rituximab treatment, Rheumatology, 2010, 49, 10, 1911
- 15, , , , Antiviral immune responses: triggers of or triggered by autoimmunity?, Nature Reviews Immunology, 2009, 9, 4, 246
- 16
- 17
- 18, , EpsteinâBarr virus in autoimmune diseases, Best Practice & Research Clinical Rheumatology, 2008, 22, 5, 883
- 19, , , , Molecular aspects of rheumatoid arthritis: role of environmental factors, FEBS Journal, 2008, 275, 18Direct Link:
- 20, , Artritis reumatoide y tropismo infeccioso, Seminarios de la Fundación Española de ReumatologÃa, 2007, 8, 2, 68
- 21, , EBV-specific T-cell response and immunosuppression by methotrexate and TNFα antagonists in patients with chronic inflammatory joint disease, Joint Bone Spine, 2007, 74, 6, 560
- 22, , , , , , Long-term treatment with methotrexate or tumor necrosis factor α inhibitors does not increase epstein-barr virus load in patients with rheumatoid arthritis, Arthritis Care & Research, 2007, 57, 5Direct Link:
- 23, , Lymphoma risk in inflammatory bowel disease: Is it the disease or its treatment?, Inflammatory Bowel Diseases, 2007, 13, 10Direct Link:
- 24, , Pathophysiological links between rheumatoid arthritis and the EpsteinâBarr virus: An update, Joint Bone Spine, 2007, 74, 5, 418
- 25, , Réponse spécifique T anti-Epstein-Barr virus et traitements par méthotrexate et anti-TNFα chez les patients atteints de rhumatismes inflammatoires chroniques, Revue du Rhumatisme, 2007, 74, 10-11, 963
- 26, , Relations physiopathologiques polyarthrite rhumatoïde et virus d'Epstein-Barr: état des lieux, Revue du Rhumatisme, 2007, 74, 9, 814
- 27, , Risks of immunosuppressive therapies including biologic agents in patients with rheumatic diseases and co-existing chronic viral infections, Current Opinion in Rheumatology, 2007, 19, 6, 619
- 28, , , Successful use of etanercept in the treatment of acute lupus hemophagocytic syndrome, Modern Rheumatology, 2007, 18, 1, 72
- 29, , Cancers au cours des maladies auto-immunes, La Revue de Médecine Interne, 2006, 27, S277
- 30, , , , , Deiminated Epstein-Barr virus nuclear antigen 1 is a target of anti–citrullinated protein antibodies in rheumatoid arthritis, Arthritis & Rheumatism, 2006, 54, 3Direct Link:
- 31, , , , , , Epstein-Barr Virus Associated Hodgkin Lymphoma in a 9-Year-Old Girl Receiving Long-Term Methotrexate Therapy for Juvenile Idiopathic Arthritis, Journal of Pediatric Hematology/Oncology, 2006, 28, 9, 622
- 32
- 33, , , What are the links between Epstein-Barr virus, lymphoma, and tumor necrosis factor antagonism in rheumatoid arthritis?, Seminars in Arthritis and Rheumatism, 2005, 34, 5, 31
- 34, Ãvénements initiaux dans la polyarthrite rhumatoïde, Revue du Rhumatisme, 2004, 71, S10
- 35, Epstein-Barr virus, arthritis, and the development of lymphoma in arthritis patients, Current Opinion in Rheumatology, 2004, 16, 4, 399
- 36, , , , , , , Epstein-Barr virus viral load in Crohn's disease. Effect of immunosuppressive therapy, Inflammatory Bowel Diseases, 2004, 10, 2Direct Link:
- 37
- 38, , , , , , , , , Reactivation of Latent Epstein-Barr Virus by Methotrexate: A Potential Contributor to Methotrexate-Associated Lymphomas, JNCI Journal of the National Cancer Institute, 2004, 96, 22, 1691

1529-0131/asset/olbannerleft.gif?v=1&s=897b81612b4ad6cae003112184adc709261d5f61)
1529-0131/asset/olbannerright.gif?v=1&s=04654f5ea3cbb01656383e0c0d04b16fd0a9a896)
1529-0131/asset/cover.gif?v=1&s=104d5c2bb8ef72deba26790b855af7ab80697a0e)